3M COMPANY Medium-Term Notes, Series F Second Amended and Restated Distribution AgreementDistribution Agreement • May 19th, 2016 • 3m Co • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 19th, 2016 Company Industry Jurisdiction3M Company, a Delaware corporation (the “Company”), proposes to issue and sell from time to time its Medium-Term Notes, Series F (the “Securities”) in an aggregate amount up to $18,000,000,000 and agrees with each of you (individually, an “Agent”, and collectively, the “Agents”) as set forth in this Second Amended and Restated Distribution Agreement (this “Agreement”). An aggregate principal amount of $8,204,156,000 of Securities were issued prior to the date of this Agreement and are currently outstanding.
3M COMPANY Medium-Term Notes, Series F Amended and Restated Distribution AgreementDistribution Agreement • May 16th, 2014 • 3m Co • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 16th, 2014 Company Industry Jurisdiction3M Company, a Delaware corporation (the “Company”), proposes to issue and sell from time to time its Medium-Term Notes, Series F (the “Securities”) in an aggregate amount up to $9,000,000,000 and agrees with each of you (individually, an “Agent”, and collectively, the “Agents”) as set forth in this Agreement. An aggregate principal amount of $2,250,000,000 of Securities were issued prior to the date of this Agreement and are currently outstanding.
3M COMPANY Medium-Term Notes, Series F Distribution AgreementDistribution Agreement • September 8th, 2011 • 3m Co • Surgical & medical instruments & apparatus • New York
Contract Type FiledSeptember 8th, 2011 Company Industry Jurisdiction3M Company, a Delaware corporation (the “Company”), proposes to issue and sell from time to time its Medium-Term Notes, Series F (the “Securities”) in an aggregate amount up to $3,000,000,000 and agrees with each of you (individually, an “Agent”, and collectively, the “Agents”) as set forth in this Agreement.